Both in Biotechnology
Artiva Biotherapeutics vs ProKidney
Over the past year ARTV returned +140.8% and PROK returned −34.3%; their daily moves had a correlation of 0.09.
ARTV +140.8% PROK −34.3%Growth of $1, one year, split-adjusted
| Metric | ARTV | PROK |
|---|---|---|
| Price | $7.03 | $1.63 |
| Market cap | $343.7M | $340.6M |
| Today | −0.28% | +1.24% |
| 1 month | −36.6% | −10.9% |
| 6 months | +29.0% | +0.6% |
| Year to date | +63.9% | −27.2% |
| 1 year | +137.5% | −34.5% |
| Revenue growth (YoY) | — | −32.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −18948.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 416.3× |
| Net cash | $349.4M | $181.6M |
| Dividend yield | — | — |
| Volatility (60d) | 67.2% | 68.6% |
| Short % of float | 15.1% | 24.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).